APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medical Hemostatic Agents

Mechanical agents (also called passive substances) are generally thought to be the most effective for small amounts of bleeding and they create a barrier to stop blood flow and a surface that permits blood to clot more rapidly.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Mechanical agents (also called passive substances) are generally thought to be the most effective for small amounts of bleeding and they create a barrier to stop blood flow and a surface that permits blood to clot more rapidly.

Selected research

Industry Growth & Trends

Global Medical Hemostatic Agents Industry Growth and Trends Forecast to 2032

28 December 2025105 pages

Choose your research edition.

Industry ResearchMedical Hemostatic Agents Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Medical Hemostatic Agents Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Medical Hemostatic Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medical Hemostatic Agents Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Medical Hemostatic Agents Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Mechanical agents (also called passive substances) are generally thought to be the most effective for small amounts of bleeding and they create a barrier to stop blood flow and a surface that permits blood to clot more rapidly.

North America is the largest consumption region, with a more than 40% market share. Then Europe is the second largest consumption region with the market share of about 30%. J&J, Baxter, BD, Gelita, Pfizer, B Braun are the leaders of the global Medical Hemostatic Agents market, and they hold more than 65% market share. Medical Hemostatic Agents is widely used in Hospital, Surgical Centers and other field. The most proportion of Medical Hemostatic Agents is Hospital, and the sales proportion is about 65%. The classification of Medical Hemostatic Agents includes Gelation Hemostats, Combination Hemostats and Others Type. The proportion of Combination Hemostats and Gelation Hemostats in 2019 is more than 50%.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Medical Hemostatic Agents market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Medical Hemostatic Agents market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Medical Hemostatic Agents market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Medical Hemostatic Agents.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Medical Hemostatic Agents market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Medical Hemostatic Agents Market by Company

J&J

Baxter

BD

Gelita

Pfizer

B Braun

CSL Behring

Ferrosan Medical Devices

Advance Medical Solution

Medtronic

Z-Medica

Marine Polymer

Equimedical

CryoLife

Medical Hemostatic Agents Segment by Type

Gelation Hemostats

Combination Hemostats

Others

Medical Hemostatic Agents Segment by Application

Hospitals

Surgical Centers

Others

Medical Hemostatic Agents Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Hemostatic Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Hemostatic Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Hemostatic Agents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Medical Hemostatic Agents manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Medical Hemostatic Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Gelation Hemostats Table 2. Major Company of Combination Hemostats Table 3. Major Company of Others Table 4. Global Medical Hemostatic Agents Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Medical Hemostatic Agents Sales by Type (2021-2026) & (K Units) Table 6. Global Medical Hemostatic Agents Sales Market Share in Volume by Type (2021-2026) Table 7. Global Medical Hemostatic Agents Sales by Type (2021-2026) & (US$ Million) Table 8. Global Medical Hemostatic Agents Sales Market Share in Value by Type (2021-2026) Table 9. Global Medical Hemostatic Agents Price by Type (2021-2026) & (US$/Unit) Table 10. Global Medical Hemostatic Agents Sales by Type (2027-2032) & (K Units) Table 11. Global Medical Hemostatic Agents Sales Market Share in Volume by Type (2027-2032) Table 12. Global Medical Hemostatic Agents Sales by Type (2027-2032) & (US$ Million) Table 13. Global Medical Hemostatic Agents Sales Market Share in Value by Type (2027-2032) Table 14. Global Medical Hemostatic Agents Price by Type (2027-2032) & (US$/Unit) Table 15. North America Medical Hemostatic Agents Sales by Type (2021-2026) & (K Units) Table 16. North America Medical Hemostatic Agents Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Medical Hemostatic Agents Sales by Type (2021-2026) & (K Units) Table 18. Europe Medical Hemostatic Agents Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Medical Hemostatic Agents Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Medical Hemostatic Agents Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Medical Hemostatic Agents Sales by Type (2021-2026) & (K Units) Table 22. Latin America Medical Hemostatic Agents Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Medical Hemostatic Agents Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Medical Hemostatic Agents Sales by Type (2021-2026) & (US$ Million) Table 25. Medical Hemostatic Agents Industry Trends Table 26. Medical Hemostatic Agents Industry Drivers Table 27. Medical Hemostatic Agents Industry Opportunities and Challenges Table 28. Medical Hemostatic Agents Industry Restraints Table 29. Global Medical Hemostatic Agents Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Medical Hemostatic Agents Revenue Market Share by Company (2021-2026) Table 31. Global Medical Hemostatic Agents Sales by Company (2021-2026) & (K Units) Table 32. Global Medical Hemostatic Agents Sales Share by Company (2021-2026) Table 33. Global Medical Hemostatic Agents Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Medical Hemostatic Agents Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Medical Hemostatic Agents Major Company Production Sites and Headquarters Table 36. Global Medical Hemostatic Agents Company, Product Type & Application Table 37. Global Medical Hemostatic Agents Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Medical Hemostatic Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Medical Hemostatic Agents Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Medical Hemostatic Agents Sales by Region (2021-2026) & (K Units) Table 42. Global Medical Hemostatic Agents Sales Market Share in Volume by Region (2021-2026) Table 43. Global Medical Hemostatic Agents Sales by Region (2021-2026) & (US$ Million) Table 44. Global Medical Hemostatic Agents Sales Market Share in Value by Region (2021-2026) Table 45. Global Medical Hemostatic Agents Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Medical Hemostatic Agents Sales by Region (2027-2032) & (K Units) Table 47. Global Medical Hemostatic Agents Sales Market Share in Volume by Region (2027-2032) Table 48. Global Medical Hemostatic Agents Sales by Region (2027-2032) & (US$ Million) Table 49. Global Medical Hemostatic Agents Sales Market Share in Value by Region (2027-2032) Table 50. Global Medical Hemostatic Agents Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Medical Hemostatic Agents Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Medical Hemostatic Agents Sales by Application (2021-2026) & (K Units) Table 53. Global Medical Hemostatic Agents Sales Market Share in Volume by Application (2021-2026) Table 54. Global Medical Hemostatic Agents Sales by Application (2021-2026) & (US$ Million) Table 55. Global Medical Hemostatic Agents Sales Market Share in Value by Application (2021-2026) Table 56. Global Medical Hemostatic Agents Price by Application (2021-2026) & (US$/Unit) Table 57. Global Medical Hemostatic Agents Sales by Application (2027-2032) & (K Units) Table 58. Global Medical Hemostatic Agents Sales Market Share in Volume by Application (2027-2032) Table 59. Global Medical Hemostatic Agents Sales by Application (2027-2032) & (US$ Million) Table 60. Global Medical Hemostatic Agents Sales Market Share in Value by Application (2027-2032) Table 61. Global Medical Hemostatic Agents Price by Application (2027-2032) & (US$/Unit) Table 62. North America Medical Hemostatic Agents Sales by Application (2021-2026) & (K Units) Table 63. North America Medical Hemostatic Agents Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Medical Hemostatic Agents Sales by Application (2021-2026) & (K Units) Table 65. Europe Medical Hemostatic Agents Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Medical Hemostatic Agents Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Medical Hemostatic Agents Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Medical Hemostatic Agents Sales by Application (2021-2026) & (K Units) Table 69. Latin America Medical Hemostatic Agents Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Medical Hemostatic Agents Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Medical Hemostatic Agents Sales by Application (2021-2026) & (US$ Million) Table 72. J&J Company Information Table 73. J&J Business Overview Table 74. J&J Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. J&J Medical Hemostatic Agents Product Portfolio Table 76. J&J Recent Development Table 77. Baxter Company Information Table 78. Baxter Business Overview Table 79. Baxter Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Baxter Medical Hemostatic Agents Product Portfolio Table 81. Baxter Recent Development Table 82. BD Company Information Table 83. BD Business Overview Table 84. BD Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. BD Medical Hemostatic Agents Product Portfolio Table 86. BD Recent Development Table 87. Gelita Company Information Table 88. Gelita Business Overview Table 89. Gelita Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Gelita Medical Hemostatic Agents Product Portfolio Table 91. Gelita Recent Development Table 92. Pfizer Company Information Table 93. Pfizer Business Overview Table 94. Pfizer Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Pfizer Medical Hemostatic Agents Product Portfolio Table 96. Pfizer Recent Development Table 97. B Braun Company Information Table 98. B Braun Business Overview Table 99. B Braun Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. B Braun Medical Hemostatic Agents Product Portfolio Table 101. B Braun Recent Development Table 102. CSL Behring Company Information Table 103. CSL Behring Business Overview Table 104. CSL Behring Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. CSL Behring Medical Hemostatic Agents Product Portfolio Table 106. CSL Behring Recent Development Table 107. Ferrosan Medical Devices Company Information Table 108. Ferrosan Medical Devices Business Overview Table 109. Ferrosan Medical Devices Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Ferrosan Medical Devices Medical Hemostatic Agents Product Portfolio Table 111. Ferrosan Medical Devices Recent Development Table 112. Advance Medical Solution Company Information Table 113. Advance Medical Solution Business Overview Table 114. Advance Medical Solution Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Advance Medical Solution Medical Hemostatic Agents Product Portfolio Table 116. Advance Medical Solution Recent Development Table 117. Medtronic Company Information Table 118. Medtronic Business Overview Table 119. Medtronic Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Medtronic Medical Hemostatic Agents Product Portfolio Table 121. Medtronic Recent Development Table 122. Z-Medica Company Information Table 123. Z-Medica Business Overview Table 124. Z-Medica Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Z-Medica Medical Hemostatic Agents Product Portfolio Table 126. Z-Medica Recent Development Table 127. Marine Polymer Company Information Table 128. Marine Polymer Business Overview Table 129. Marine Polymer Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Marine Polymer Medical Hemostatic Agents Product Portfolio Table 131. Marine Polymer Recent Development Table 132. Equimedical Company Information Table 133. Equimedical Business Overview Table 134. Equimedical Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Equimedical Medical Hemostatic Agents Product Portfolio Table 136. Equimedical Recent Development Table 137. CryoLife Company Information Table 138. CryoLife Business Overview Table 139. CryoLife Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. CryoLife Medical Hemostatic Agents Product Portfolio Table 141. CryoLife Recent Development Table 142. North America Medical Hemostatic Agents Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. North America Medical Hemostatic Agents Sales by Country (2021-2026) & (K Units) Table 144. North America Medical Hemostatic Agents Sales Market Share by Country (2021-2026) Table 145. North America Medical Hemostatic Agents Sales Forecast by Country (2027-2032) & (K Units) Table 146. North America Medical Hemostatic Agents Sales Market Share Forecast by Country (2027-2032) Table 147. North America Medical Hemostatic Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. North America Medical Hemostatic Agents Market Size by Country (2021-2026) & (US$ Million) Table 149. North America Medical Hemostatic Agents Market Share by Country (2021-2026) Table 150. North America Medical Hemostatic Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. North America Medical Hemostatic Agents Market Share Forecast by Country (2027-2032) Table 152. Europe Medical Hemostatic Agents Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. Europe Medical Hemostatic Agents Sales by Country (2021-2026) & (K Units) Table 154. Europe Medical Hemostatic Agents Sales Market Share by Country (2021-2026) Table 155. Europe Medical Hemostatic Agents Sales Forecast by Country (2027-2032) & (K Units) Table 156. Europe Medical Hemostatic Agents Sales Market Share Forecast by Country (2027-2032) Table 157. Europe Medical Hemostatic Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Europe Medical Hemostatic Agents Market Size by Country (2021-2026) & (US$ Million) Table 159. Europe Medical Hemostatic Agents Market Share by Country (2021-2026) Table 160. Europe Medical Hemostatic Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Europe Medical Hemostatic Agents Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Medical Hemostatic Agents Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Medical Hemostatic Agents Sales by Country (2021-2026) & (K Units) Table 164. Asia-Pacific Medical Hemostatic Agents Sales Market Share by Country (2021-2026) Table 165. Asia-Pacific Medical Hemostatic Agents Sales Forecast by Country (2027-2032) & (K Units) Table 166. Asia-Pacific Medical Hemostatic Agents Sales Market Share Forecast by Country (2027-2032) Table 167. Asia-Pacific Medical Hemostatic Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Asia-Pacific Medical Hemostatic Agents Market Size by Country (2021-2026) & (US$ Million) Table 169. Asia-Pacific Medical Hemostatic Agents Market Share by Country (2021-2026) Table 170. Asia-Pacific Medical Hemostatic Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Asia-Pacific Medical Hemostatic Agents Market Share Forecast by Country (2027-2032) Table 172. Latin America Medical Hemostatic Agents Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 173. Latin America Medical Hemostatic Agents Sales by Country (2021-2026) & (K Units) Table 174. Latin America Medical Hemostatic Agents Sales Market Share by Country (2021-2026) Table 175. Latin America Medical Hemostatic Agents Sales Forecast by Country (2027-2032) & (K Units) Table 176. Latin America Medical Hemostatic Agents Sales Market Share Forecast by Country (2027-2032) Table 177. Latin America Medical Hemostatic Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Latin America Medical Hemostatic Agents Market Size by Country (2021-2026) & (US$ Million) Table 179. Latin America Medical Hemostatic Agents Market Share by Country (2021-2026) Table 180. Latin America Medical Hemostatic Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Latin America Medical Hemostatic Agents Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Medical Hemostatic Agents Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Medical Hemostatic Agents Sales by Country (2021-2026) & (K Units) Table 184. Middle East and Africa Medical Hemostatic Agents Sales Market Share by Country (2021-2026) Table 185. Middle East and Africa Medical Hemostatic Agents Sales Forecast by Country (2027-2032) & (K Units) Table 186. Middle East and Africa Medical Hemostatic Agents Sales Market Share Forecast by Country (2027-2032) Table 187. Middle East and Africa Medical Hemostatic Agents Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 188. Middle East and Africa Medical Hemostatic Agents Market Size by Country (2021-2026) & (US$ Million) Table 189. Middle East and Africa Medical Hemostatic Agents Market Share by Country (2021-2026) Table 190. Middle East and Africa Medical Hemostatic Agents Market Size Forecast by Country (2027-2032) & (US$ Million) Table 191. Middle East and Africa Medical Hemostatic Agents Market Share Forecast by Country (2027-2032) Table 192. Key Raw Materials Table 193. Raw Materials Key Suppliers Table 194. Medical Hemostatic Agents Distributors List Table 195. Medical Hemostatic Agents Customers List Table 196. Research Programs/Design for This Report Table 197. Authors List of This Report Table 198. Secondary Sources Table 199. Primary Sources List of Figures Figure 1. Medical Hemostatic Agents Image Figure 2. Global Medical Hemostatic Agents Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medical Hemostatic Agents Market Size (2021-2032) & (US$ Million) Figure 4. Global Medical Hemostatic Agents Sales (2021-2032) & (K Units) Figure 5. Gelation Hemostats Image Figure 6. Global Gelation Hemostats Sales YoY Growth (2021-2032) & (K Units) Figure 7. Combination Hemostats Image Figure 8. Global Combination Hemostats Sales YoY Growth (2021-2032) & (K Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Medical Hemostatic Agents Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Medical Hemostatic Agents Market Share by Type 2025 VS 2032 Figure 13. North America Medical Hemostatic Agents Sales Market Share in Volume by Type in 2025 Figure 14. North America Medical Hemostatic Agents Sales Market Share in Value by Type in 2025 Figure 15. Europe Medical Hemostatic Agents Sales Market Share in Volume by Type in 2025 Figure 16. Europe Medical Hemostatic Agents Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Medical Hemostatic Agents Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Medical Hemostatic Agents Sales Market Share in Value by Type in 2025 Figure 19. Latin America Medical Hemostatic Agents Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Medical Hemostatic Agents Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Medical Hemostatic Agents Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Medical Hemostatic Agents Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Medical Hemostatic Agents Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospitals Image Figure 26. Global Hospitals Sales YoY Growth (2021-2032) & (K Units) Figure 27. Surgical Centers Image Figure 28. Global Surgical Centers Sales YoY Growth (2021-2032) & (K Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Medical Hemostatic Agents Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Medical Hemostatic Agents Market Share by Application 2025 VS 2032 Figure 33. North America Medical Hemostatic Agents Sales Market Share in Volume by Application in 2025 Figure 34. North America Medical Hemostatic Agents Sales Market Share in Value by Application in 2025 Figure 35. Europe Medical Hemostatic Agents Sales Market Share in Volume by Application in 2025 Figure 36. Europe Medical Hemostatic Agents Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Medical Hemostatic Agents Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Medical Hemostatic Agents Sales Market Share in Value by Application in 2025 Figure 39. Latin America Medical Hemostatic Agents Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Medical Hemostatic Agents Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Medical Hemostatic Agents Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Medical Hemostatic Agents Sales Market Share in Value by Application in 2025 Figure 43. North America Medical Hemostatic Agents Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Medical Hemostatic Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Medical Hemostatic Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Medical Hemostatic Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Medical Hemostatic Agents Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Medical Hemostatic Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Medical Hemostatic Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Medical Hemostatic Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Medical Hemostatic Agents Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Medical Hemostatic Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Medical Hemostatic Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Medical Hemostatic Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Medical Hemostatic Agents Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Medical Hemostatic Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Medical Hemostatic Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Medical Hemostatic Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Medical Hemostatic Agents Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Medical Hemostatic Agents Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Medical Hemostatic Agents Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Medical Hemostatic Agents Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Medical Hemostatic Agents Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Medical Hemostatic Agents Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Gelation Hemostats
  • Combination Hemostats
  • Others
Applications
  • Hospitals
  • Surgical Centers
  • Others
Companies covered
  • J&J
  • Baxter
  • BD
  • Gelita
  • Pfizer
  • B Braun
  • CSL Behring
  • Ferrosan Medical Devices
  • Advance Medical Solution
  • Medtronic
  • Z-Medica
  • Marine Polymer
  • Equimedical
  • CryoLife

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Medical Hemostatic Agents Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Medical Hemostatic Agents Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Medical Hemostatic Agents Market by Type
  6. 1.3.1 Gelation Hemostats
  7. 1.3.2 Combination Hemostats
  8. 1.3.3 Others
  9. 1.4 Global Medical Hemostatic Agents Market Size by Type
  10. 1.4.1 Global Medical Hemostatic Agents Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Medical Hemostatic Agents Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Medical Hemostatic Agents Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Medical Hemostatic Agents Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Medical Hemostatic Agents Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Medical Hemostatic Agents Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Medical Hemostatic Agents Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Medical Hemostatic Agents Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Medical Hemostatic Agents Industry Trends
  2. 2.2 Medical Hemostatic Agents Industry Drivers
  3. 2.3 Medical Hemostatic Agents Industry Opportunities and Challenges
  4. 2.4 Medical Hemostatic Agents Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Medical Hemostatic Agents Revenue (2021-2026)
  2. 3.2 Global Top Players by Medical Hemostatic Agents Sales (2021-2026)
  3. 3.3 Global Top Players by Medical Hemostatic Agents Price (2021-2026)
  4. 3.4 Global Medical Hemostatic Agents Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Medical Hemostatic Agents Major Company Production Sites & Headquarters
  6. 3.6 Global Medical Hemostatic Agents Company, Product Type & Application
  7. 3.7 Global Medical Hemostatic Agents Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Medical Hemostatic Agents Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Medical Hemostatic Agents Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Medical Hemostatic Agents Tier 1, Tier 2, and Tier 3
4 Medical Hemostatic Agents Regional Status and Outlook
  1. 4.1 Global Medical Hemostatic Agents Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Medical Hemostatic Agents Historic Market Size by Region
  3. 4.2.1 Global Medical Hemostatic Agents Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Medical Hemostatic Agents Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Medical Hemostatic Agents Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Medical Hemostatic Agents Forecasted Market Size by Region
  7. 4.3.1 Global Medical Hemostatic Agents Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Medical Hemostatic Agents Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Medical Hemostatic Agents Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Medical Hemostatic Agents by Application
  1. 5.1 Medical Hemostatic Agents Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Surgical Centers
  4. 5.1.3 Others
  5. 5.2 Global Medical Hemostatic Agents Market Size by Application
  6. 5.2.1 Global Medical Hemostatic Agents Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Medical Hemostatic Agents Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Medical Hemostatic Agents Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Medical Hemostatic Agents Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Medical Hemostatic Agents Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Medical Hemostatic Agents Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Medical Hemostatic Agents Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Medical Hemostatic Agents Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 J&J
  2. 6.1.1 J&J Company Information
  3. 6.1.2 J&J Business Overview
  4. 6.1.3 J&J Medical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 J&J Medical Hemostatic Agents Product Portfolio
  6. 6.1.5 J&J Recent Developments
  7. 6.2 Baxter
  8. 6.2.1 Baxter Company Information
  9. 6.2.2 Baxter Business Overview
  10. 6.2.3 Baxter Medical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Baxter Medical Hemostatic Agents Product Portfolio
  12. 6.2.5 Baxter Recent Developments
  13. 6.3 BD
  14. 6.3.1 BD Company Information
  15. 6.3.2 BD Business Overview
  16. 6.3.3 BD Medical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 BD Medical Hemostatic Agents Product Portfolio
  18. 6.3.5 BD Recent Developments
  19. 6.4 Gelita
  20. 6.4.1 Gelita Company Information
  21. 6.4.2 Gelita Business Overview
  22. 6.4.3 Gelita Medical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Gelita Medical Hemostatic Agents Product Portfolio
  24. 6.4.5 Gelita Recent Developments
  25. 6.5 Pfizer
  26. 6.5.1 Pfizer Company Information
  27. 6.5.2 Pfizer Business Overview
  28. 6.5.3 Pfizer Medical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Pfizer Medical Hemostatic Agents Product Portfolio
  30. 6.5.5 Pfizer Recent Developments
  31. 6.6 B Braun
  32. 6.6.1 B Braun Company Information
  33. 6.6.2 B Braun Business Overview
  34. 6.6.3 B Braun Medical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 B Braun Medical Hemostatic Agents Product Portfolio
  36. 6.6.5 B Braun Recent Developments
  37. 6.7 CSL Behring
  38. 6.7.1 CSL Behring Company Information
  39. 6.7.2 CSL Behring Business Overview
  40. 6.7.3 CSL Behring Medical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 CSL Behring Medical Hemostatic Agents Product Portfolio
  42. 6.7.5 CSL Behring Recent Developments
  43. 6.8 Ferrosan Medical Devices
  44. 6.8.1 Ferrosan Medical Devices Company Information
  45. 6.8.2 Ferrosan Medical Devices Business Overview
  46. 6.8.3 Ferrosan Medical Devices Medical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Ferrosan Medical Devices Medical Hemostatic Agents Product Portfolio
  48. 6.8.5 Ferrosan Medical Devices Recent Developments
  49. 6.9 Advance Medical Solution
  50. 6.9.1 Advance Medical Solution Company Information
  51. 6.9.2 Advance Medical Solution Business Overview
  52. 6.9.3 Advance Medical Solution Medical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Advance Medical Solution Medical Hemostatic Agents Product Portfolio
  54. 6.9.5 Advance Medical Solution Recent Developments
  55. 6.10 Medtronic
  56. 6.10.1 Medtronic Company Information
  57. 6.10.2 Medtronic Business Overview
  58. 6.10.3 Medtronic Medical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Medtronic Medical Hemostatic Agents Product Portfolio
  60. 6.10.5 Medtronic Recent Developments
  61. 6.11 Z-Medica
  62. 6.11.1 Z-Medica Company Information
  63. 6.11.2 Z-Medica Business Overview
  64. 6.11.3 Z-Medica Medical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Z-Medica Medical Hemostatic Agents Product Portfolio
  66. 6.11.5 Z-Medica Recent Developments
  67. 6.12 Marine Polymer
  68. 6.12.1 Marine Polymer Company Information
  69. 6.12.2 Marine Polymer Business Overview
  70. 6.12.3 Marine Polymer Medical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Marine Polymer Medical Hemostatic Agents Product Portfolio
  72. 6.12.5 Marine Polymer Recent Developments
  73. 6.13 Equimedical
  74. 6.13.1 Equimedical Company Information
  75. 6.13.2 Equimedical Business Overview
  76. 6.13.3 Equimedical Medical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Equimedical Medical Hemostatic Agents Product Portfolio
  78. 6.13.5 Equimedical Recent Developments
  79. 6.14 CryoLife
  80. 6.14.1 CryoLife Company Information
  81. 6.14.2 CryoLife Business Overview
  82. 6.14.3 CryoLife Medical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 CryoLife Medical Hemostatic Agents Product Portfolio
  84. 6.14.5 CryoLife Recent Developments
7 North America by Country
  1. 7.1 North America Medical Hemostatic Agents Sales by Country
  2. 7.1.1 North America Medical Hemostatic Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Medical Hemostatic Agents Sales by Country (2021-2026)
  4. 7.1.3 North America Medical Hemostatic Agents Sales Forecast by Country (2027-2032)
  5. 7.2 North America Medical Hemostatic Agents Market Size by Country
  6. 7.2.1 North America Medical Hemostatic Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Medical Hemostatic Agents Market Size by Country (2021-2026)
  8. 7.2.3 North America Medical Hemostatic Agents Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Medical Hemostatic Agents Sales by Country
  2. 8.1.1 Europe Medical Hemostatic Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Medical Hemostatic Agents Sales by Country (2021-2026)
  4. 8.1.3 Europe Medical Hemostatic Agents Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Medical Hemostatic Agents Market Size by Country
  6. 8.2.1 Europe Medical Hemostatic Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Medical Hemostatic Agents Market Size by Country (2021-2026)
  8. 8.2.3 Europe Medical Hemostatic Agents Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Medical Hemostatic Agents Sales by Country
  2. 9.1.1 Asia-Pacific Medical Hemostatic Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Medical Hemostatic Agents Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Medical Hemostatic Agents Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Medical Hemostatic Agents Market Size by Country
  6. 9.2.1 Asia-Pacific Medical Hemostatic Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Medical Hemostatic Agents Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Medical Hemostatic Agents Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Medical Hemostatic Agents Sales by Country
  2. 10.1.1 South America Medical Hemostatic Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Medical Hemostatic Agents Sales by Country (2021-2026)
  4. 10.1.3 South America Medical Hemostatic Agents Sales Forecast by Country (2027-2032)
  5. 10.2 South America Medical Hemostatic Agents Market Size by Country
  6. 10.2.1 South America Medical Hemostatic Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Medical Hemostatic Agents Market Size by Country (2021-2026)
  8. 10.2.3 South America Medical Hemostatic Agents Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Medical Hemostatic Agents Sales by Country
  2. 11.1.1 Middle East and Africa Medical Hemostatic Agents Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Medical Hemostatic Agents Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Medical Hemostatic Agents Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Medical Hemostatic Agents Market Size by Country
  6. 11.2.1 Middle East and Africa Medical Hemostatic Agents Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Medical Hemostatic Agents Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Medical Hemostatic Agents Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Medical Hemostatic Agents Value Chain Analysis
  2. 12.1.1 Medical Hemostatic Agents Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Medical Hemostatic Agents Production Mode & Process
  7. 12.2 Medical Hemostatic Agents Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Medical Hemostatic Agents Distributors
  10. 12.2.3 Medical Hemostatic Agents Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst